Product Images Buprenorphine And Naloxone
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 4 images provide visual information about the product associated with Buprenorphine And Naloxone NDC 70518-3487 by Remedyrepack Inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
Remedy_Label - Remedy Label
Buprenorphine/Naloxone is a prescription tablet containing 2mg/0.5mg of medication for sublingual use. The package comes with 30 tablets of Orepack, distributed by G-l. Prescription only with an NDC number 70518-3487-00 and manufactured by Rhades Pharma in Caveritry, Rl 02816. The medication should be kept out of reach of children, stored at 20-25°C (58-77°F), with excursions allowed to 15-30°C (50-86°F) [See USP]. The drug is not for transfer to anyone other than the patient for whom it was prescribed. The package insert contains usage instructions. The tablets were repackaged by RemedyRepack Inc. in Indiana, PA 15701.*
Chemical Structure - buprenorphine 01
HCI stands for Human-Computer Interaction. It is a multidisciplinary field that focuses on the design, development, and evaluation of computer systems that are accessible, usable, and enjoyable for humans to use. HCI combines elements of computer science, psychology, design, and engineering to optimize the interaction between users and computers. The goal of HCI is to improve the quality of the user experience when interacting with technology, making it more intuitive, efficient, and satisfying.*
Chemical Structure - buprenorphine 02
Image - buprenorphine 03
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.
